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The mechanisms underlying innate immune cell trafficking and activation during infection remain incom-
pletely defined. In this issue of Immunity, Kang et al. (2008) begin to reveal the cytokine and chemokine cas-
cades that coordinate cellular responses induced by microbial pathogens.Viruses, bacteria, protozoa, and fungi
have evolved a range of mechanisms for
invading mammalian hosts and causing
infectious diseases. To cause infection
and survive within a mammalian host, mi-
crobes activate virulence programs that
enable them to survive or escape antimi-
crobial defenses. Most infectious dis-
eases share a common theme: Microbial
virulence mechanisms enable access to
host compartments that are generally off
limits to microbes and thereby induce
innate immune and inflammatory re-
sponses that, in turn, promote the devel-
opment and differentiation of adaptive im-
mune responses. Kang et al. (2008) have
extended our understanding of the innate
immune response to infection with Listeria
monocytogenes by providing a more ex-
act spatial and temporal context for the
contributions of CD11c dendritic cells,
natural killer (NK) cells, inflammatory
monocytes, and interleukin-12 (IL-12),
IL-18, and interferon-g (IFN-g) in defense
against intracellular bacterial infection
(Kang et al., 2008).
L. monocytogenes, a Gram-positive
bacterium that causes systemic infec-
tions in a broad range of mammals, has
served as a useful model for dissecting
the interactions between a microbial
pathogen and the mammalian immune
system (Pamer, 2004). In the case of
L. monocytogenes infection, the mi-
crobe’s virulence strategy begins with in-
vasion of mammalian cells in order to es-
cape extracellular antimicrobial factors. In
contrast to most intracellular bacteria,
however, L. monocytogenes goes one
step further and escapes the vacuolar
compartment by secreting listeriolysin
O (LLO), a membranolytic protein that en-
ables internalized bacteria to enter the672 Immunity 29, November 14, 2008 ª200host cell cytosol. Production of LLO and
escape from the vacuole are essential
for L. monocytogenes virulence, and bac-
teria lacking LLO are avirulent. In addition,
L. monocytogenes lacking LLO do not in-
duce in vivo inflammatory responses as-
sociated with virulent infection. In mice,
priming of L. monocytogenes-specific
CD4+ and CD8+ T cells, which provide
long-term immunity to reinfection, is
heavily influenced by innate inflammatory
responses induced during the first few
days of infection. Thus, cytosol invasion
by L. monocytogenes induces a cascade
of inflammatory events that include induc-
tion of cytokines and chemokines, orga-
nized recruitment of distinct cell popula-
tions, and early restriction of in vivo
bacterial replication. These early events
are essential for survival because, in their
absence, bacterial growth occurs so rap-
idly that mice die within 72 to 96 hr, and
they are essential for the effective priming
and differentiation of responding T cells
(Pamer, 2004).
Experiments with mice lacking different
cytokines or cytokine and chemokine
receptors have demonstrated that some
of these molecules are essential for
L. monocytogenes clearance whereas
others impair early bacterial clearance.
Mice lacking IL-10 or the receptor for
type I interferons, for example, are more
resistant to L. monocytogenes infection,
indicating that these cytokines restrict
protective immune defenses. In contrast,
mice lacking IFN-g, tumor necrosis factor
(TNF), inducible nitric oxide synthase
(iNOS), or the CCR2 chemokine receptor
are far more susceptible to L. monocyto-
genes infection, indicating that these
factors are essential for innate immune
defense (Pamer, 2004). These findings8 Elsevier Inc.led to a relatively simple model of innate
immune defense against L. monocyto-
genes: bacteria infect macrophages and
monocytes that, upon activation by
IFN-g and/or TNF, produce iNOS and kill
intracellular bacteria.
Further studies, however, revealed that
the actual mechanisms for in vivo defense
against L. monocytogenes infection are
more complex. Histologic analyses of in-
fected spleens revealed that systemically
administered L. monocytogenes are first
localized to the marginal zone and are
then carried by dendritic cells to the
T cell zones of the splenic white pulp
(Aoshi et al., 2008; Conlan, 1996). Concur-
rent with but independent of these early
events in the spleen, CCR2-mediated sig-
nals promote emigration of monocytes
from bone marrow into the blood stream
and eventually to infected tissues, where
monocytes differentiate to produce high
amounts of TNF and iNOS and limit bacte-
rial replication. This recruitment process
results from the induction of the chemo-
kines MCP-1 (monocyte chemoattractant
protein 1) and MCP-3, but how infected
tissues, such as the spleen and liver after
L. monocytogenes infection, signal to the
bone marrow to release CCR2+ mono-
cytes into the circulation remains unclear
(Jia et al., 2008).
In this issue, Kang et al. have investi-
gated the activation of newly recruited
monocytes to the spleen and discovered
some important and essential cytokine-
and chemokine-mediated interactions
between CD11c+ DCs, NK cells, and
Ly6Chi monocytes during the early innate
immune response to L. monocytogenes
infection. Staining of infected spleen for
NK cells and inflammatory monocytes in
combination with cell-depletion strategies
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PreviewsFigure 1. Sequential Activation of Innate Immune Responses during Bacterial Infection
After systemic administration of L. monocytogenes, dendritic cells (DCs) transport bacteria to the white-pulp areas of the spleen, where they initiate secretion of
chemokines required for recruitment of natural killer (NK) cells and monocytes (left). DCs undergo MyD88-dependent activation and secrete IL-12 and IL-18 that
in turn activate newly recruited NK cells to produce IFN-g. Recruited cells are organized in clusters; monocytes are positioned in proximity to infected cells, and
NK cells form a cuff at the periphery (middle). NK-derived IFN-g inducesmonocyte activation. Monocyte activation leads to upregulation ofMHCclass II and iNOS
expression and subsequent differentiation into TipDCs. TipDCs sensemicrobial infection in aMyD88-dependentmanner and secrete TNF-a and nitric oxide (NO),
ultimately leading to restriction of bacterial replication (right).revealed that both cell populations inde-
pendently colocalize at sites of infection
and that NK cells form a cuff surrounding
aggregated monocytes (Figure 1). Inter-
estingly, recruitment of these two cell
populations is concurrent, suggesting
that, within the spleen, they might be re-
sponding to the same stimulus. The de-
velopment of a new IFN-g reporter mouse
strain allowed the investigators to demon-
strate that NK cells are the predominant
producers of IFN-g in the inflammatory
aggregates and that IFN-g induces differ-
entiation of recruited monocytes into
TNF- and iNOS-producing dendritic cells
(Tip-DCs).
Kang et al. next investigated the role of
CD11c-expressing dendritic cells in the
early aggregation of NK cells and mono-
cytes after L. monocytogenes infection.
Remarkably, in mice lacking CD11c
DCs, recruitment of monocytes and NK
cells was almost completely turned off,
suggesting that DCs orchestrate or at
least facilitate the early inflammatory pro-
cess. One caveat of this experiment, how-
ever, is that DCs play an important role in
splenic infection, and as demonstrated in
this study and a previous study (Neuen-
hahn et al., 2006), mice lacking DCs
have markedly reduced splenic infection
with L. monocytogenes after systemic in-
oculation. NK cell recruitment appears to
be regulated, at least in part, by CCR5,
a chemokine receptor that binds and re-
sponds to MIP-1a, MIP-1b, and RANTES.
Thus, an attractive, straightforward, but
unproven scenario is that DCs, in re-
sponse to L. monocytogenes infection,
secrete the chemokines that recruit NKcells and perhaps inflammatory mono-
cytes to form the inflammatory aggre-
gates.
Mice lacking MyD88 are highly suscep-
tible to L. monocytogenes infection
(Pamer, 2004). Toll-like receptor signaling
is not required for monocyte recruitment
to the infected spleen, but monocyte dif-
ferentiation is impaired at the site of infec-
tion (Serbina et al., 2003). Kang et al. dem-
onstrate that IFN-g is diminished in the
absence of MyD88-mediated signals.
MyD88 signaling might be required for
IL-12 and IL-18 secretion by CD11c+
DCs and subsequent activation of NK
cell-mediated IFN-g production.
Recruitment of inflammatory cells and
induction of chemokine secretion requires
cytosol invasion by virulent L. monocyto-
genes. Avirulent L. monocytogenes that
remain within the host cell vacuole, in
contrast, induce far less chemokine se-
cretion (Serbina et al., 2003). The identi-
ties of the receptor that detects cytosol in-
vasion and the microbial ligands that
stimulate chemokine secretion remain un-
known. Kang et al. studied mice with de-
letions of some candidate cytosolic innate
immune receptors or signaling molecules,
Nod1, Nod2, ASC, and IFR3, but were not
able to identify the pathway that initiates
aggregation of NK cells and monocytes
after L. monocytogenes infection. It is
possible that these innate immune signal-
ing pathways drive this process in parallel
and that the absence of one pathway
alone is insufficient to ablate the inflam-
matory response to cytosol invasion.
This scenario will be important but difficult
to address and might require complexImmunity 29,breeding strategies for obtaining double,
triple, and potentially quadruple gene-de-
leted mice.
Although recruitment and activation of
monocytes has been most completely
characterized in mice infected with
L. monocytogenes, the mechanisms un-
derlying this process are relevant to infec-
tions with other pathogens and mono-
cyte-mediated inflammatory processes
that cause human disease. Increasingly,
monocyte recruitment has been shown
to play an essential role in defense against
a spectrum of different microbial infec-
tions, including Toxoplasmosis, Crypto-
coccosis, Salmonella, and Mycobacte-
rium tuberculosis infection (Serbina
et al., 2008). Monocyte recruitment and
activation have also been implicated in
vascular and demyelinating diseases
such as atherosclerosis andmultiple scle-
rosis (Gerard and Rollins, 2001), respec-
tively, and TipDCs have been identified
as important contributors to the patho-
genesis of psoriasis (Lowes et al., 2005).
Defining the mechanisms that promote
monocyte recruitment and activation,
therefore, might provide opportunities to
promote defense against a range of infec-
tions and, in settings of overly robust in-
flammatory responses, opportunities to
ameliorate pathologic states.
REFERENCES
Aoshi, T., Zinselmeyer, B.H., Konjufca, V., Lynch,
J.N., Zhang, X., Koide, Y., and Miller, M.J. (2008).
Immunity 29, 476–486.
Conlan, J.W. (1996). J. Med. Microbiol. 44,
295–302.November 14, 2008 ª2008 Elsevier Inc. 673
Immunity
PreviewsGerard, C., and Rollins, B.J. (2001). Nat. Immunol.
2, 108–115.
Jia, T., Serbina, N.V., Brandl, K., Zhong, M.X.,
Leiner, I.M., Charo, I.F., and Pamer, E.G. (2008).
J. Immunol. 180, 6846–6853.
Kang, S.-J., Liang, H.-E., Reizis, B., and Locksley,
R.M. (2008). Immunity 29, this issue, 819–833.674 Immunity 29, November 14, 2008 ª2008Lowes, M.A., Chamian, F., Abello, M.V., Fuentes-
Duculan, J., Lin, S.L., Nussbaum, R., Novitskaya,
I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al.
(2005). Proc. Natl. Acad. Sci. USA 102,
19057–19062.
Neuenhahn, M., Kerksiek, K.M., Nauerth, M.,
Suhre, M.H., Schiemann, M., Gebhardt, F.E.,
Stemberger, C., Panthel, K., Schroder, S., Chakra-
borty, T., et al. (2006). Immunity 25, 619–630.Elsevier Inc.Pamer, E.G. (2004). Nat. Rev. Immunol. 4,
812–823.
Serbina, N.V., Jia, T., Hohl, T.M., and Pamer, E.G.
(2008). Annu. Rev. Immunol. 26, 421–452.
Serbina, N.V., Kuziel, W., Flavell, R., Akira, S.,
Rollins, B., and Pamer, E.G. (2003). Immunity 19,
891–901.
